- HOME >
- For Researchers >
- Product Search >
- Search Result >
- #18979 Anti-Human Girdin Rabbit IgG Affinity Purify
Product Search
    #18979 Anti-Human Girdin Rabbit IgG Affinity Purify
- Intended Use:
- Research reagents
- Application:
- WB, IP, ICC
- Package Size1:
- 100 μg
- Package Size2:
- 10 μg
- Note on Application Abbreviations
- WB:Western Blotting
- IP:Immunoprecipitation
- ICC:Immunocytochemistry
※ The product indicated as "Research reagents" in the column Intended Use cannot be used 
   for diagnostic nor any medical purpose.
※ The datasheet listed on this page is sample only. Please refer to the datasheet
   enclosed in the product purchased before use.
Product Overview
Product Overview
| Product Code | 18979 | 
|---|---|
| Product Name | Anti-Human Girdin Rabbit IgG Affinity Purify | 
| Intended Use | Research reagents | 
| Application | WB, IP, ICC | 
| Species | Human | 
| Immunizing antigen | Synthetic peptide of a part of Human Girdin | 
| Purification Method | Purified with protein A | 
| Package Form | Lyophilized product from 1 % BSA in PBS containing 0.05% NaN3 | 
| Storage Condition | 2 - 8℃ | 
| Poisonous and Deleterious Substances | Applicable | 
| Cartagena | Not Applicable | 
| Package Size 1 | 100 μg | 
| Package Size 2 | 10 μg | 
| Remarks1 | The commercial use of products without our permission is prohibited. Please make sure to contact us and obtain permission. | 
Product Description
Product Description
Girdin was discovered by a study group led by Takahashi as a new protein playing an important role in the infiltration and metastasis of cancer cells. It has been shown that Girdin, phosphorylated by the enzyme Akt/PKB within cancer cells, enhances the infiltration potential of cancer cells. It has, therefore, been suggested that if the activity of girdin is suppressed, it may be possible to develop a drug which can suppress the progression of cancer.
References
References
Note: Retrieve by PMID number in displayed by abstract: http://www.ncbi.nlm.nih.gov





















 
		 
		 
		 
		 
		
 
	 
 
				
								 
				
								 
				
								 
				
								 
				
								 
				
								 
				
								 
				
								 
				
								 
				
								